• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Respiratory

PerkinElmer to acquire Oxford Immunotec

January 7, 2021 By Sean Whooley

PerkinElmer (NYSE:PKI) and Oxford Immunotec announced today that they agreed to terms under which the former will acquire the latter. Under the agreement, London-based Oxford Immunotec’s shareholders will be entitled to receive $22 for each outstanding ordinary share, with the terms of the acquisition valuing Oxford Immunotec’s entire issued and to-be-issued ordinary share capital at $591 […]

Filed Under: Business/Financial News, Diagnostics, Drug-Device Combinations, Featured, Mergers & Acquisitions, Respiratory Tagged With: Oxford Immunotec, perkinelmer

Appeals court nixes GSK’s petition for new trial in Vectura patent spat

November 20, 2020 By Nancy Crotti

The Federal Circuit Court has rejected Glaxo Smith Kline’s (NYSE:GSK) petition for a new trial in a patent case brought by British inhaler company Vectura. The circuit court upheld a May 2019 jury verdict in U.S. District Court for the District of Delaware, awarding Ventura $89.7 million damages for the period from August 2016 through […]

Filed Under: Drug-Device Combinations, Featured, Legal News, Respiratory Tagged With: GlaxoSmithKline plc, Vectura

FDA produces list of ‘essential’ devices, drugs for health, military emergencies

November 2, 2020 By Nancy Crotti

FDA-logo-new

The FDA has released a list of essential medical devices, medicines and “medical countermeasures” that the Trump administration ordered the agency to buy domestically to fight the novel coronavirus and future health and military crises. Devices on the list include diagnostic testing kits and supplies for rapid test development and processing, personal protective equipment, devices […]

Filed Under: Cardiovascular, Drug-Device Combinations, Hospital Care, Patient Monitoring, Pharmaceuticals, Respiratory Tagged With: Donald Trump, FDA

Amazon, Onica to support digital health for Teva’s Digihaler

October 22, 2020 By Sean Whooley

Teva Respiratory (NYSE:TEVA) announced that it is collaborating with Amazon Web Services (AWS) and Onica to build and host its digital health platform. The Teva Pharmaceuticals affiliate’s digital health platform is a cloud-based backend data system designed to support its FDA-approved Digihaler portfolio of breath-actuated digital inhalers and its companion mobile app that tracks inhaler events […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Respiratory, Technology Tagged With: amazon, Onica, Teva Pharmaceuticals

Teva launches 2 digital inhalers in U.S.

September 23, 2020 By Sean Whooley

Teva Respiratory (NYSE:TEVA) announced that it launched its AirDuo Digihaler and ArmonAir Digihaler digital inhalers in the U.S. The U.S. affiliate of Teva Pharmaceutical Industries launched both digital inhalers as treatments for asthma. The AirDuo Digihaler is a prescription inhalation powder for controlling symptoms of asthma and preventing symptoms such as wheezing in people 12 years […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory Tagged With: Teva Pharmaceuticals

Teva launches connected inhaler for asthma, COPD

July 13, 2020 By Nancy Crotti

Teva Pharmaceutical logo - updated

Teva (NYSE:TEVA) announced today that it has launched a Bluetooth-enabled version of its ProAir albuterol sulfate rescue inhaler. The ProAir Digihaler’s sensors connect to a companion mobile app to provide inhaler-use information to healthcare providers. The new inhaler is available by prescription to U.S. patients age 4 and older, according to the Tel Aviv, Israel-based company. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Teva Pharmaceuticals

FDA clears Propeller Health sensor to work with Symbocort inhaler

May 27, 2020 By Sean Whooley

Propeller Health updated logo

Propeller Health announced that it received FDA 510(k) clearance for connecting patients using its Symbicort Inhaler to its digital health platform. The Madison, Wis.-based company’s digital health platform already connects to inhalers used by asthma and COPD patients, including ones manufactured by Boehringer Ingelheim, GlaxoSmithKline, Novartis and Orion, along with other generic equivalents. Get the full […]

Filed Under: Drug-Device Combinations, Featured, Respiratory Tagged With: Propeller Health

B. Braun lands FDA EUA for use of infusion pumps with nebulizers to treat COVID-19

April 14, 2020 By Sean Whooley

B. Braun Medical announced that it received FDA emergency use authorization to use  its infusion pumps with nebulizers to treat patients with COVID-19. The Bethlehem, Pa.-based company’s authorization win includes its Perfusor space syringe infusion pump, Infusomat space volumetric infusion pump and Outlook ES pump systems. The pumps can be used for tracheal delivery of continuous […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Respiratory Tagged With: B. Braun Medical, coronavirus, COVID-19

FDA approves Cipla’s generic albuterol inhaler

April 9, 2020 By Sean Whooley

FDA-logo-new

The FDA approved the first generic version of the Proventil HFA (albuterol sulfate) metered-dose inhaler for treating bronchospasm. The FDA indicated the generic inhaler from Cipla for the treatment or prevention of bronchospasm in patients four years of age or older with reversible obstructive airway disease. It also aids in the prevention of exercise-induced bronchospasm […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: cipla, FDA

OncoSec, Inovio testing COVID-19 vaccines

April 8, 2020 By Sean Whooley

OncoSec Medical (NSDQ:ONCS) and Inovio Pharmaceuticals (NSDQ:INO) announced that they are testing potential COVID-19 vaccines after the latter received investigational new drug clearance from the FDA. Inovio received an IND nod, while OncoSec’s is pending, but both companies are pursuing a first-in-human Phase 1 clinical trial for their vaccines, according to separate news releases. OncoSec is using […]

Filed Under: Business/Financial News, Clinical Trials, Discovery, Featured, Food & Drug Administration (FDA), Immunotherapy, Pharmaceuticals, Preclinical Trials, Regulatory/Compliance, Research & Development, Respiratory Tagged With: coronavirus, COVID-19, Inovio Pharmaceuticals, OncoSec Medical

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 23
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS